GlassScriptPhysician profile
Rani U Athreya
NPI 1114000734
$1,354.33
in general payments reported to CMS, 2019-2025
12 companies · $335 in 2025
The $335 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $12.69 · 2021: $292 · 2022: $122 · 2023: $213 · 2024: $219 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529 · Education: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $529.33 |
| Education | $237.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $529.25 | 2019-2025 | |
| Harmony Biosciences LLC | $217.51 | 2021-2025 | |
| Inspire Medical Systems, INC. | $124.99 | 2023 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $124.08 | 2024 | Lumryz |
| Lilly USA, LLC | $97.78 | 2025 | Kisunla |
| Mdd US Operations, LLC | $82.53 | 2023-2025 | Gocovri |
| Medtronic USA, INC. | $59.63 | 2019 | |
| Zoll Respicardia, INC. | $30.48 | 2023 | Remede System |
| Noctrix Health, INC. | $30.30 | 2025 | Nidra |
| Impel Pharmaceuticals INC. | $20.58 | 2023 | Trudhesa |
| Argenx US, INC. | $18.61 | 2024 | Vyvgart Hytrulo |
| Medtronic, INC. | $18.59 | 2023 | Percept PC Brainsense |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rani Athreya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.